Hypoxia-induced activation of HIF as well as pharmacologic inhibition of HIF-hydroxylases induces transcription of genes including erythropoietin (EPO) and its receptor transferrin in vivo and in vitro, thereby ameliorating anemia [36,37]. This evidence concerns the gene EPO and anemia.